Patents by Inventor Wendy Yoder

Wendy Yoder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210388310
    Abstract: Provided are methods and compositions useful for producing filamentous fungal cells and compounds produced by such cells that have utility in a variety of applications. In one aspect, provided herein is a method for producing a SLR from a filamentous fungal cell, wherein the method comprises the steps of: a) growing the filamentous fungal cell in a first medium comprising a first carbon source to obtain an actively growing mycelial culture, and b) replacing the first medium of the actively growing mycelial culture with a second medium comprising a second carbon source to induce production of the SLR; wherein the first carbon source comprises a metabolizable carbon compound, wherein the second carbon source comprises only non-metabolizable carbon compounds, and wherein the second medium comprises no other carbon source than the second carbon source.
    Type: Application
    Filed: September 20, 2019
    Publication date: December 16, 2021
    Inventors: Timothy Geistlinger, Brian Darst, Timo Schuerg, Balakrishnan Ramesh, Wendy Yoder
  • Patent number: 9790532
    Abstract: The present invention relates to methods of producing a polypeptide, comprising: (a) cultivating a mutant of a parent Fusarium venenatum strain in a medium for the production of the polypeptide, wherein the mutant strain comprises a polynucleotide encoding the polypeptide and one or more (several) genes selected from the group consisting of pyrG, amyA, and alpA, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of orotidine-5?-monophosphate decarboxylase, alpha-amylase, and alkaline protease, respectively, compared to the parent Fusarium venenatum strain when cultivated under identical conditions; and (b) recovering the polypeptide from the cultivation medium. The present invention also relates to enzyme-deficient mutants of Fusarium venenatum strains and methods for producing such mutants.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: October 17, 2017
    Assignee: Novozymes, Inc.
    Inventors: Jeffrey Shasky, Wendy Yoder
  • Publication number: 20170145462
    Abstract: The present invention relates to methods of producing a polypeptide, comprising: (a) cultivating a mutant of a parent Fusarium venenatum strain in a medium for the production of the polypeptide, wherein the mutant strain comprises a polynucleotide encoding the polypeptide and one or more (several) genes selected from the group consisting of pyrG, amyA, and alpA, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of orotidine-5?-monophosphate decarboxylase, alpha-amylase, and alkaline protease, respectively, compared to the parent Fusarium venenatum strain when cultivated under identical conditions; and (b) recovering the polypeptide from the cultivation medium. The present invention also relates to enzyme-deficient mutants of Fusarium venenatum strains and methods for producing such mutants.
    Type: Application
    Filed: January 27, 2017
    Publication date: May 25, 2017
    Applicant: Novozymes, Inc.
    Inventors: Jeffrey Shasky, Wendy Yoder
  • Patent number: 9593342
    Abstract: The present invention relates to methods of producing a polypeptide, comprising: (a) cultivating a mutant of a parent Fusarium venenatum strain in a medium for the production of the polypeptide, wherein the mutant strain comprises a polynucleotide encoding the polypeptide and one or more (several) genes selected from the group consisting of pyrG, amyA, and alpA, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of orotidine-5?-monophosphate decarboxylase, alpha-amylase, and alkaline protease, respectively, compared to the parent Fusarium venenatum strain when cultivated under identical conditions; and (b) recovering the polypeptide from the cultivation medium. The present invention also relates to enzyme-deficient mutants of Fusarium venenatum strains and methods for producing such mutants.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: March 14, 2017
    Assignee: NOVOZYMES, INC.
    Inventors: Jeffrey Shasky, Wendy Yoder
  • Publication number: 20160102315
    Abstract: The present invention relates to methods of producing a polypeptide, comprising: (a) cultivating a mutant of a parent Fusarium venenatum strain in a medium for the production of the polypeptide, wherein the mutant strain comprises a polynucleotide encoding the polypeptide and one or more (several) genes selected from the group consisting of pyrG, amyA, and alpA, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of orotidine-5?-monophosphate decarboxylase, alpha-amylase, and alkaline protease, respectively, compared to the parent Fusarium venenatum strain when cultivated under identical conditions; and (b) recovering the polypeptide from the cultivation medium. The present invention also relates to enzyme-deficient mutants of Fusarium venenatum strains and methods for producing such mutants.
    Type: Application
    Filed: December 18, 2015
    Publication date: April 14, 2016
    Applicant: NOVOZYMES, INC.
    Inventors: Jeffrey Shasky, Wendy Yoder
  • Patent number: 9255275
    Abstract: The present invention relates to methods of producing a polypeptide, comprising: (a) cultivating a mutant of a parent Fusarium venenatum strain in a medium for the production of the polypeptide, wherein the mutant strain comprises a polynucleotide encoding the polypeptide and one or more (several) genes selected from the group consisting of pyrG, amyA, and alpA, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of orotidine-5?-monophosphate decarboxylase, alpha-amylase, and alkaline protease, respectively, compared to the parent Fusarium venenatum strain when cultivated under identical conditions; and (b) recovering the polypeptide from the cultivation medium. The present invention also relates to enzyme-deficient mutants of Fusarium venenatum strains and methods for producing such mutants.
    Type: Grant
    Filed: January 30, 2014
    Date of Patent: February 9, 2016
    Assignee: NOVOZYMES, INC.
    Inventors: Jeffrey Shasky, Wendy Yoder
  • Publication number: 20140147847
    Abstract: The present invention relates to methods of producing a polypeptide, comprising: (a) cultivating a mutant of a parent Fusarium venenatum strain in a medium for the production of the polypeptide, wherein the mutant strain comprises a polynucleotide encoding the polypeptide and one or more (several) genes selected from the group consisting of pyrG, amyA, and alpA, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of orotidine-5?-monophosphate decarboxylase, alpha-amylase, and alkaline protease, respectively, compared to the parent Fusarium venenatum strain when cultivated under identical conditions; and (b) recovering the polypeptide from the cultivation medium. The present invention also relates to enzyme-deficient mutants of Fusarium venenatum strains and methods for producing such mutants.
    Type: Application
    Filed: January 30, 2014
    Publication date: May 29, 2014
    Inventors: Jeffrey Shasky, Wendy Yoder
  • Patent number: 8647856
    Abstract: The present invention relates to methods of producing a polypeptide, comprising: (a) cultivating a mutant of a parent Fusarium venenatum strain in a medium for the production of the polypeptide, wherein the mutant strain comprises a polynucleotide encoding the polypeptide and one or more (several) genes selected from the group consisting of pyrG, amyA, and alpA, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of orotidine-5?-monophosphate decarboxylase, alpha-amylase, and alkaline protease, respectively, compared to the parent Fusarium venenatum strain when cultivated under identical conditions; and (b) recovering the polypeptide from the cultivation medium. The present invention also relates to enzyme-deficient mutants of Fusarium venenatum strains and methods for producing such mutants.
    Type: Grant
    Filed: September 30, 2009
    Date of Patent: February 11, 2014
    Assignee: Novozymes Inc.
    Inventors: Jeffrey Shasky, Wendy Yoder
  • Publication number: 20110236928
    Abstract: The present invention relates to methods of producing a polypeptide, comprising: (a) cultivating a mutant of a parent Fusarium venenatum strain in a medium for the production of the polypeptide, wherein the mutant strain comprises a polynucleotide encoding the polypeptide and one or more (several) genes selected from the group consisting of pyrG, amyA, and alpA, wherein the one or more (several) genes are modified rendering the mutant strain deficient in the production of one or more (several) enzymes selected from the group consisting of orotidine-5?-monophosphate decarboxylase, alpha-amylase, and alkaline protease, respectively, compared to the parent Fusarium venenatum strain when cultivated under identical conditions; and (b) recovering the polypeptide from the cultivation medium. The present invention also relates to enzyme-deficient mutants of Fusarium venenatum strains and methods for producing such mutants.
    Type: Application
    Filed: September 30, 2009
    Publication date: September 29, 2011
    Applicant: Novozymes, Inc
    Inventors: Jeffrey Shasky, Wendy Yoder
  • Publication number: 20110223671
    Abstract: The present invention relates to methods for using positively and negatively selectable genes in a filamentous fungal cell to delete, disrupt, or insert a gene in a filamentous fungal cell.
    Type: Application
    Filed: September 30, 2009
    Publication date: September 15, 2011
    Applicant: Novozymes, Inc.
    Inventors: Wendy Yoder, Jeffrey Shasky
  • Publication number: 20050181480
    Abstract: The present invention relates to methods for producing a polypeptide, comprising: (a) cultivating a mutant of a parent filamentous fungal cell under conditions conducive for the production of the polypeptide, wherein (i) the mutant cell comprises a first nucleic acid sequence encoding the polypeptide and a second nucleic acid sequence comprising a modification of at least one of the genes involved in the production of a trichothecene and (ii) the mutant produces less of the trichothecene than the parent filamentous fungal cell when cultured under the same conditions; and (b) isolating the polypeptide from the cultivation medium. The present invention also relates to mutants of filamentous fungal cells and methods for obtaining the mutant cells. The present invention also relates to isolated trichodiene synthases and isolated nucleic acid sequences encoding the trichodiene synthases.
    Type: Application
    Filed: March 31, 2005
    Publication date: August 18, 2005
    Applicant: Novozymes Biotech, Inc.
    Inventors: John Royer, Lynne Christianson, Gregory Gambetta, Howard Brody, Suzanne Otani, Wendy Yoder
  • Patent number: 5667990
    Abstract: The present invention relates to a novel expression system in which A. japonicus-type species are used as host cells for expression of heterologous proteins.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: September 16, 1997
    Assignee: Novo Nordisk Biotech, Inc.
    Inventors: Randy Michael Berka, Wendy Yoder, Shinobu Takagi, Karuppan Chettier Boominathan